Evaluating the Medication Adherence From the Viewpoints of Patients With Mental Disorders and Their Families

References

• 1.
  Sadock BJ, Sadock VA. Kaplan and Sadocks synopsis of psychiatry: Behavioral sciences/clinical psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2011. https://books.google.com/ books?id=fFi7DR2hmaIC&dq.
• 2.
  Manjunatha N, Singh G. Manochaitanya: Integrating mental health into primary health care. Lancet. 2016; 387(10019):6478.[DOI:10.1016/S0140-6736(16)00286-5] [PMID].
• 3.
  Sarrami H, Ghorbani M, Minooei M. Survey of four decades of addiction prevalence researches in Iran. J Res Addict. 2013; 7(26):2952. [In Persian] http://etiadpajohi.ir/article-1-286-en.html.
• 4.
  Sadeghian E, Afshar Moghadam F. Determination of factors affecting the medication compliance in patients admitted to psychiatric wards. J Qazvin Univ Med Sci. 2005; 9(3):26-33. [In Persian] http://journal.qums.ac.ir/article-1-721-en.html.
• 5.
  Neathery M. Treatment and spiritual care in mental health: Recovery as a journey, not a Destination. J Christ Nurs. 2018; 35(2):86-92. [DOI:10.1097/CNJ.0000000000000475] [PMID].
• 6.
  Sadock BJ, Sadock VA, Kaplan HI. Kaplan and Sadocks concise textbook of child and adolescent psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2009. https://books.google.com/ books?id=DUFZ9NP2GK0C&dq.
• 7.
  Charpentier A, Goudemand M, Thomas P. Therapeutic alliance, a stake in Schizophrenia. Encephale. 2009; 35(1):80-9. [In French] [DOI:10.1016/j.encep.2007.12.009] [PMID].
• 8.
  Ebrahimi H, Ranjbar F, Namdar H, Mosaffa F. The effect of therapeutic relationship in schizophrenic patients. J Urmia Nurs Midwifery Fac. 2014; 12(6):491-8. [In Persian] http://unmf. umsu.ac.ir/article-1-1636-en.html.
• 9.
  Arnow BA, Steidtmann D, Blasey C, Manber R, Constantino MJ, Klein DN, et al. The relationship between the therapeutic alliance and treatment outcome in two distinct psychotherapies for chronic depression. J Consult Clin Psychol. 2013; 81(4):62738. [DOI:10.1037/a0031530] [PMID] [PMCID].
• 10.
  Morrison M, Valfre MM. Foundations of mental health nursing. Maryland Heights: Mosby; 1997 https://books.google. com/books?id=V7NrAAAAMAAJ&q.
• 11.
  Steger KA, Cassidy C, Rabinovitch M, Joober R, Malla A. Impact of symptom resolution on medication adherence in first episode psychosis. Psychiatry Res. 2012; 196(1):45-51. [DOI:10.1016/j.psychres.2011.10.015] [PMID].
• 12.
  Minaiyan M, Taheri M, Mirmoghtadaee P, Marasi M. Comparative role of demographic factors and patients belief about prescribed medicine on adherence to drug treatment in chronic diseases. J Isfahan Med Sch. 2011; 29(156):1303-11. https://www.sid.ir/fa/journal/ViewPaper.aspx?ID=148351.
• 13.
  Yadollahi S, Ashktorab T, Zayeri F. Medication adherence and related factors in patients with epilepsy. Hayat. 2015; 21(2):6780. [In Persian] http://hayat.tums.ac.ir/article-1-1135-en.html.
• 14.
  Horne R, Weinman J. Patients beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47(6):555-67. [DOI:10.1016/S0022-3999(99)00057-4] [PMID].
• 15.
  Schoenthaler A, Chaplin WF, Allegrante JP, Fernandez S, Diaz-Gloster M, Tobin JN, et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns. 2009; 75(2):185-91. [DOI:10.1016/j. pec.2008.09.018] [PMID] [PMCID].
• 16.
  Chaturvedi A, Singh y, Kalra J, Bhandari V, Dhashena DC, Ahmad S, et al. Do all non-responders to anti-hypertensive medication need a change in medication regimen? Journal, Indian Academy of Clinical Medicine. 2009; 10(1-2):32-5. https:// www.researchgate.net/profile/Yogendra_Singh35/publication/265563018.
• 17.
  Ferrari CMM, de Sousa RMC, Castro LHM. Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure. 2013; 22(5):384-9. [DOI:10.1016/j.seii zure.2013.02.006] [PMID].
• 18.
  Ettinger AB, Good MB, Manjunath R, Faught RE, Bancroft T. The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy Behav. 2014; 36:138-43. [DOI:10.1016/j.yebeh.2014.05.011] [PMID].
• 19.
  Hunt R. Introduction to community-based nursing. Philadelphia: Lippincott Williams & Wilkins; 2009. https://books. google.com/books?id=LRu9WC-5vysC&dq.
• 20.
  Reiter JT, Dobmeyer AC, Hunter CL. The Primary Care Behavioral Health (PCBH) model: An overview and operational definition. J Clin Psychol Med Settings. 2018; 25(2):109-26. [DOI:10.1007/s10880-017-9531-x] [PMID].
• 21.
  Gordon E, Kenny M. Group work in psychiatric/mental health nursing: The case for psychoeducation as a means to therapeutic ends. In: Santos JC, Cutcliffe JR, editors. European Psychiatric/Mental Health Nursing in the 21st Century. Cham; Springer: 2018. pp. 269-82. https://books.google.com/ books?id=Ph5KDwAAQBAJ&dq.
• 22.
  Namdar H, Ebrahimi H, Yazdani M, Safaeian A. Non-compliance with medication regimens in patients with Schizophrenia. Iran J Psychiatry Clin Psychol. 2006; 11(4):463-66. [In Persian] http://ijpcp.iums.ac.ir/article-1-53-en.html.
• 23.
  Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. [DOI:10.1111/j.1751-7176.2008.07572.x] [PMID].
• 24.
  Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AA, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the morisky medication adherence scale in patients with type 2 diabetes. Iran J Rehab Res Nurs. 2015; 1(3):24-32. [In Persian] http://ijrn.ir/article-1-98-en.html.
• 25.
  Staring ABP, Van der Gaag M, Koopmans GT, Selten JP, Van Beveren JM, Hengeveld MW, et al. Treatment adherence therapy in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry. 2010; 197(6):448-55. [DOI:10.1192/bjp. bp.110.077289] [PMID].
• 26.
  Sweileh WM, Zyoud SH, Abu Naba RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patients disease knowledge and beliefs about medicines on medication adherence: Findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014; 14:94. [DOI:10.1186/1471-2458-14-94] [PMID] [PMCID].
• 27.
  Mashrouteh M, Khanjani N, Gozashti MH. Evaluation of compliance with drug regimens in diabetic patients referred to the endocrinology clinic of Afzalipour Hospital, Kerman, Iran. Health Dev J. 2012; 1(3):182-92. [In Persian] http:// jhad.kmu.ac.ir/article-1-12-en.html.
• 28.
  Tang F, Zhu G, Jiao Z, Ma C, Wang B. Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China. Epilepsy Behav. 2013; 27(1):85-9. [DOI:10.1016/j.yebeh.2012.12.022] [PMID].
• 29.
  Hovinga CA, Asato MR, Manjunath R, Wheless JW, Phelps SJ, Sheth RD, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians. Epilepsy Behav. 2008; 13(2):316-22. [DOI:10.1016/j.yebeh.2008.03.009] [PMID].
• 30.
  Getachew H, Dekema NH, Awol SS , Abdi AA , Mohammed MA. Medication adherence in epilepsy and potential risk factors associated with non adherence in tertiary care teaching hospital in southwest Ethiopia. Gaziantep Med J. 2014; 20(1):59-65. [DOI:10.5455/GMJ-30-45904].
• 31.
  Johnbull OS, Farounbi B, Adeleye AO, Ogunrin O, Uche AP. Evaluation of factors influencing medication adherence in patients with epilepsy in rural communities of Kaduna State, Nigeria. Neurosci Med. 2011; 2(04):299-305. [DOI:10.4236/nm.2011.24039.
• 32.
  Gabr WM, Shams MEE. Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J. 2015; 23(1):33-40. [DOI:10.1016/j.jsps.2014.05.003] [PMID] [PMCID].
• 33.
  Liu J, Liu z, Ding H, Yang X. Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Epileptic Disord. 2013; 15(3):289-94. [DOI:10.1684/epd.2013.0588] [PMID]##.